Clinical Research Trials

The advancement of science through research.

As a dedicated clinical trial hub, we believe in advancing science through research. We understand each study has the potential of providing treatment for various diseases and disorders. We keep up with the literature and believe in keeping our patients informed.

Our services are closely coordinated with patients, families, sponsors, and regulatory organizations to obtain solid data with strong enrollment in our trials, ensuring high-quality and on-time services. Most importantly, we take excellent care of our patients, ensuring this is a good experience.

FDA-approved Clinical trials are conducted according to a protocol designed by the sponsor and monitored by the IRB. The protocol describes what type of patients may enter the study, schedules of visits, labs, and other procedures, drugs, length of study, and the data/outcomes that will be measured. Each person participating in the study must provide consent before participating. We will clearly outline the study design, help you arrange your appointments, and describe step by step what you can expect when you join a clinical trial.

If you are interested in learning more about our research and finding a clinical trial that best fits you, please get in touch with us to help you throughout the process of evaluation, enrolling, and participating in a research study.

Clinical Trial Experience

ADHD

Autism Spectrum Disorder

Alzheimer's dementia

Bipolar disorder

Chronic Pain

Fibromyalgia

Opiate Use Disorder

Schizophrenia

Schizoaffective disorder

Prior Clinical Trials

Central Nervous System & Psychiatric Disorders

  • Phase 3 multicenter, randomized, double-blind trial evaluating a fixed-dose investigational therapy as combination treatment for adults with PTSD

  • Phase 3 multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of an investigational compound for major depressive disorder

  • Double-blind, single- and multiple-dose study evaluating pharmacodynamic markers, pharmacokinetics, and safety of an investigational therapy in major depressive disorder

  • Prospective multicenter real-world evidence study characterizing the natural history of tardive dyskinesia (TD) and evaluating the effectiveness of an investigational agent

  • Open-label 1-year safety study of an investigational therapy in adolescent patients with schizophrenia or bipolar I disorder

  • Randomized, double-blind, placebo-controlled study with open-label extension evaluating adjunctive investigational therapy for adults with major depressive disorder

  • Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of an investigational agent as adjunctive treatment in major depressive disorder

  • Randomized, double-blind, placebo-controlled study with open-label extension assessing an investigational treatment for adults with bipolar disorder experiencing a major depressive episode

Pediatric CNS & Behavioral Health

  • Randomized, double-blind, placebo-controlled multicenter study evaluating the efficacy and safety of an investigational therapy for irritability associated with autism spectrum disorder (ages 5–17)

  • Randomized, double-blind, placebo-controlled multicenter study assessing an investigational treatment for major depressive episodes associated with bipolar I or bipolar II disorder in pediatric patients (ages 10–17)

  • Open-label multicenter trial assessing safety and tolerability of an investigational compound in pediatric patients with schizophrenia, bipolar disorder, or autism spectrum disorder

Neurodegenerative Disorders

  • Extended study evaluating an investigational therapy for cognitive impairment in Alzheimer’s disease

  • Extended study assessing an investigational compound in Alzheimer’s patients with MMSE scores 14–24

  • Extended study evaluating an investigational therapy in Alzheimer’s patients with MMSE scores 12–22

  • Study assessing the effect of an investigational therapy on agitation and aggressiveness in Alzheimer’s disease

Metabolic & Pain Disorders

  • Study evaluating the effect of an investigational therapy in diabetic neuropathy

  • Extended study assessing the efficacy of an investigational treatment in diabetic peripheral neuropathy

  • Extended study comparing the efficacy of an investigational compound versus placebo in fibromyalgia